Training: ESAGON (European Institute of Oncology): Difference between revisions

From Beacon
No edit summary
m (Update categories.)
Line 1: Line 1:
{{forproviders}} {{forresearchers}}
<span style="display:none">forproviders</span> <span style="display:none">forresearchers</span>
Go back to [[European Institute of Oncology]] page
Go back to [[European Institute of Oncology]] page


Line 10: Line 10:
'''Information:''' [https://www.ieo.it/it/FORMAZIONE/IEO-Education/Esagon/About-Us Click here to access].
'''Information:''' [https://www.ieo.it/it/FORMAZIONE/IEO-Education/Esagon/About-Us Click here to access].


{{Vulva}}
<span style="display:none">Vulva</span>
{{Vagina}}
<span style="display:none">Vagina</span>
{{Cervix}}
<span style="display:none">Cervix</span>
{{Uterus}}
<span style="display:none">Uterus</span>
{{Ovary}}
<span style="display:none">Ovary</span>
{{Fallopian tubes}}
<span style="display:none">Fallopian tubes</span>
{{Endometrium}}
<span style="display:none">Endometrium</span>
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span>

Revision as of 13:57, 2 December 2025

forproviders forresearchers Go back to European Institute of Oncology page

Primary purpose: To provide advanced post-graduate training in gynaecologic oncology, focusing on innovative technology and a multidisciplinary approach, with a special emphasis on the management of ovarian cancer.

Target audience: Doctors.

Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.

Information: Click here to access.

Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium hasCancerType::C51-C58: Female genitalia cancer